In 2025, at least 50 COVID-19 vaccines have received authorization in one or more countries — meaning they have been approved, licensed, or granted emergency use authorization by national regulatory authorities around the world in 201 country. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Abdala, Zifivax, Corbevax, COVIran Barekat, and SCB-2019. Of the 50 vaccines, 16 have a full or emergency authorization in only one country, 12 in ten or fewer countries, and 12 in more than ten countries. Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination program; however, they are recognized for the purpose of travel to Australia.
Overview maps
Oxford–AstraZeneca The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, was a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark, and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine was the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine was administered in more countries than any other vaccine. The vaccine is no longer in production. AstraZeneca withdrew its marketing authorizations for the vaccine from the European market in March 2024, and worldwide by May 2024.
Full (5)
Emergency (170)
Pfizer–BioNTech The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.
Original Full (39)
Emergency (145)
Bivalent original–BA.1
Non-country entities
World Health Organization
Bivalent original–BA.4/5
Non-country entities
Hong Kong Macau World Health Organization
XBB.1.5 United States
JN.1 United Kingdom
KP.2 United States
Janssen The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups. The United States began use of the Janssen vaccine in March 2021, but discouraged use in favor of other available vaccines in December 2021 due to the risk of a rare clotting disorder. The Janssen vaccine became unavailable in the United States in May 2023 after all existing doses expired.
Full (4) Australia (not used) Brazil Canada Switzerland
Emergency (132)
Moderna The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.
Original
Emergency (116)
Bivalent original–BA.1
Bivalent original–BA.4/5 Brazil Taiwan
XBB.1.5 Brazil United States
JN.1 European Union Switzerland Taiwan United Kingdom
KP.2 United States
Sinopharm BIBP The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.
Full (4) Bahrain China Seychelles United Arab Emirates
Emergency (111)
Travel-only
Sputnik V The Sputnik V COVID-19 vaccine is a viral vector vaccine produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.
Full (3) Russia Turkmenistan Uzbekistan
Emergency (76)
CoronaVac The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.
Full (1) China Non-country entities
Hong Kong
Emergency (71)
Travel-only
Novavax The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations.
Full (4) Australia Canada Japan South Korea
Covaxin Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.
Full (1) India Emergency (50)
Travel-only
VLA2001 VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.
Full (1) United Kingdom
Travel-only Malaysia New Zealand Turkey
Sanofi–GSK The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a subunit vaccine developed by Sanofi Pasteur and GSK plc. It is based on the SARS-CoV-2 Beta variant.
Sputnik Light Sputnik Light is a viral vector vaccine, produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.
Full (0) Emergency (28)
Travel-only Malaysia New Zealand Turkey
Convidecia Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.
Full (1) China Emergency (9) Argentina Chile Ecuador Hungary Indonesia Malaysia Mexico Moldova Pakistan Non-country entities
World Health Organization Travel-only Hong Kong Japan New Zealand Turkey
Sinopharm WIBP The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.
Full (1) China Emergency (5) Armenia North Macedonia Peru Philippines United Arab Emirates Venezuela Travel-only Hong Kong Malaysia New Zealand Turkey
Abdala Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.
Full (0) Emergency (6) Cuba Mexico Nicaragua St. Vincent and the Grenadines Venezuela Vietnam Travel-only Cambodia Colombia Guyana Malaysia New Zealand St. Lucia Turkey Uruguay (only if accepted in the country of the person's origin)
EpiVacCorona EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.
Full (1) Turkmenistan Emergency (4) Belarus Cambodia Russia Venezuela Travel-only Malaysia New Zealand Turkey
Zifivax Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.
Full (0) Emergency (5) China Colombia Indonesia Pakistan Uzbekistan Travel-only Hong Kong Malaysia New Zealand Turkey
Soberana 02 Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.
Full (0) Emergency (4) Cuba Iran Nicaragua Venezuela Travel-only Guyana Hungary Malaysia New Zealand Turkey
CoviVac CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.
Full (0) Emergency (3) Belarus Cambodia Russia Travel-only Malaysia New Zealand Turkey
QazCovid-in QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.
Full (0) Emergency (2) Kazakhstan Kyrgyzstan Travel-only Malaysia New Zealand Turkey
Minhai Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.
Full (0) Emergency (2) China Indonesia Travel-only Hong Kong Malaysia New Zealand Turkey
Medigen MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.
Full (0) Emergency (3) Eswatini Taiwan Paraguay Non-country entities 1. Somaliland
Travel-only Belize Indonesia Malaysia New Zealand Palau Thailand Turkey
Corbevax Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.
Full (0) Emergency (2) India Botswana Travel-only Malaysia New Zealand Turkey
COVIran Barekat COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.
Full (0) Emergency (2) Iran Nicaragua Travel-only
Malaysia New Zealand Hungary Turkey
Chinese Academy of Medical Sciences Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.
Full (0) Emergency (1) China Travel-only Hong Kong New Zealand Turkey
ZyCoV-D ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.
Full (0) Emergency (1) India Travel-only Malaysia New Zealand Turkey
FAKHRAVAC FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.
Full (0) Emergency (1) Iran Travel-only Hungary Malaysia New Zealand Turkey
COVAX-19 COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.
Full (0) Emergency (1) Iran Travel-only Hungary Malaysia New Zealand Turkey
Razi Cov Pars Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.
Full (0) Emergency (1) Iran Travel-only Hungary Malaysia New Zealand Turkey
Turkovac Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.
Full (0) Emergency (1) Turkey Travel-only Malaysia New Zealand
Sinopharm CNBG Sinopharm CNBG COVID-19 vaccine (NVSI) is a recombinant protein subunit vaccine developed by the National Vaccine & Serum Institute (NVSI, 中生研究院), a subsidiary of China National Biotec Group (CNBG), which in turn is a subsidiary of Sinopharm.
Full (0) Emergency (1) United Arab Emirates Travel-only Malaysia Turkey
Soberana Plus Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.
Full (0) Emergency (2) Belarus Cuba Travel-only Guyana Malaysia New Zealand Turkey
CoVLP CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana benthamiana. It was developed by Medicago, and is marketed under the name Covifenz Archived 24 February 2022 at the Wayback Machine.
Full (1) Canada Emergency (0) Travel-only Malaysia New Zealand Turkey
Noora Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.
Full (0) Emergency (1) Iran Travel-only Malaysia Turkey
SKYCovione SKYCovione is a protein subunit vaccine developed by SK Bioscience.
Full (0) Emergency (1) South Korea
Walvax Walvax COVID-19 vaccine is an RNA vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences, and the PLA Academy of Military Science.
Full (0) Emergency (1) Indonesia
iNCOVACC iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics, and Washington University School of Medicine.
Full (0) Emergency (1) India
Gemcovac Gemcovac, or GEMCOVAC-19, is a self-amplifying mRNA vaccine manufactured by Gennova Biopharmaceuticals.
Full (0) Emergency (1) India
V-01 V-01 is a protein subunit vaccine developed by Livzon Mabpharm.
Full (0) Emergency (1) China
IndoVac IndoVac is a protein subunit vaccine developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine.
Full (0) Emergency (1) Indonesia
Notes
References